卵巢储备功能低下妇女接受体外受精时采用温和卵巢刺激策略:一项多中心随机非劣效性试验
这项开放标签多中心随机非劣效性试验纳入卵巢储备功能低下且接受体外受精的妇女,比较低剂量促性腺激素(150 IU FSH)联合GnRH拮抗剂的温和刺激方案与高剂量促性腺激素(450 IU HMG)联合长方案GnRH激动剂的常规刺激方案。结果显示温和刺激组持续妊娠率为12.8%(25/195),常规刺激组为13.6%(27/199),风险比为0.95(95% CI:0.57-1.57),绝对差为-0.7%(95% CI:-7.4至5.9),95% CI未超出预设的10%非劣效界值。温和刺激方案缩短了刺激持续时间并减少了促性腺激素用量。
要点
- 温和刺激组持续妊娠率12.8%(25/195),常规刺激组13.6%(27/199),风险比0.95(95% CI:0.57-1.57)。
- 绝对差-0.7%(95% CI:-7.4至5.9),95% CI未超出预设的10%非劣效界值。
- 温和刺激组刺激持续时间较短(均数差-1.2天,95% CI:-1.88至-0.62),促性腺激素用量较少(均数差3135 IU,95% CI:-3331至-2940)。
核心结论
- 在卵巢储备功能低下且接受体外受精的妇女中,温和卵巢刺激策略导致的持续妊娠率与常规卵巢刺激策略相似。
研究设计与样本
- 开放标签多中心随机非劣效性试验,于2011年5月至2014年4月开展,比较一个周期的温和卵巢刺激方案(低剂量促性腺激素150 IU FSH联合GnRH拮抗剂)与一个周期的常规卵巢刺激方案(高剂量促性腺激素450 IU HMG联合长方案中期黄体期起始GnRH激动剂)。
- 纳入标准为女性年龄≥35岁、基础FSH水平>10 IU/ml(不论年龄)、窦卵泡计数低至≤5个、或既往体外受精周期卵巢反应不良或周期取消(不论年龄)。
- 共随机分配195名妇女至温和卵巢刺激组,199名妇女至常规卵巢刺激组,主要结局为每名随机化妇女的持续妊娠率,按意向性分析。
主要发现
- 温和卵巢刺激组持续妊娠率为12.8%(25/195),常规卵巢刺激组为13.6%(27/199),风险比为0.95(95% CI:0.57-1.57),绝对差为-0.7%(95% CI:-7.4至5.9)。
- 该95% CI未延伸至预设的10%非劣效界值以下。
- 温和卵巢刺激组的卵巢刺激持续时间显著低于常规卵巢刺激组(均数差-1.2天,95% CI:-1.88至-0.62)。
- 温和卵巢刺激组的促性腺激素用量显著较低(均数差3135 IU,95% CI:-3331至-2940)。
临床怎么用
- 作者指出结果可直接应用于日常临床实践,并可能因卵巢储备功能低下妇女接受体外受精时不需要高剂量促性腺激素而带来可观的成本节约。
- 作者提到计划进行健康经济学分析以检验温和卵巢刺激策略比常规卵巢刺激策略更具成本效果的假设,该分析正在进行中。
局限性
- 研究缺乏关于剩余胚胎冷冻保存的数据,因此无法获得累积妊娠率的信息。
- 另一个局限性是无法在所有中心对持续妊娠进行随访,因此无法获得活产率的信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: In subfertile women with poor ovarian reserve undergoing IVF does a mild ovarian stimulation strategy lead to comparable ongoing pregnancy rates in comparison to a conventional ovarian stimulation strategy? SUMMARY ANSWER: A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF leads to similar ongoing pregnancy rates as a conventional ovarian stimulation strategy. WHAT IS KNOWN ALREADY: Women diagnosed with poor ovarian reserve are treated with a conventional ovarian stimulation strategy consisting of high-dose gonadotropins and pituitary downregulation with a long mid-luteal start GnRH-agonist protocol. Previous studies comparing a conventional strategy with a mild ovarian stimulation strategy consisting of low-dose gonadotropins and pituitary downregulation with a GnRH-antagonist have been under powered and their effectiveness is inconclusive. STUDY DESIGN, SIZE, DURATION: This open label multicenter randomized trial was designed to compare one cycle of a mild ovarian stimulation strategy consisting of low-dose gonadotropins (150 IU FSH) and pituitary downregulation with a GnRH-antagonist to one cycle of a conventional ovarian stimulation strategy consisting of high-dose gonadotropins (450 IU HMG) and pituitary downregulation with a long mid-luteal GnRH-agonist in women of advanced maternal age and/or women with poor ovarian reserve undergoing IVF between May 2011 and April 2014. PARTICIPANTS/MATERIALS, SETTING, METHODS: Couples seeking infertility treatment were eligible if they fulfilled the following inclusion criteria: female age ≥35 years, a raised basal FSH level >10 IU/ml irrespective of age, a low antral follicular count of ≤5 follicles or poor ovarian response or cycle cancellation during a previous IVF cycle irrespective of age. The primary outcome was ongoing pregnancy rate per woman randomized. Analyses were on an intention-to-treat basis. We randomly assigned 195 women to the mild ovarian stimulation strategy and 199 women to the conventional ovarian stimulation strategy. MAIN RESULTS AND THE ROLE OF CHANCE: Ongoing pregnancy rate was 12.8% (25/195) for mild ovarian stimulation versus 13.6% (27/199) for conventional ovarian stimulation leading to a risk ratio of 0.95 (95% CI: 0.57-1.57), representing an absolute difference of -0.7% (95% CI: -7.4 to 5.9). This 95% CI does not extend below the predefined threshold of 10% for inferiority. The duration of ovarian stimulation was significantly lower in the mild ovarian stimulation strategy than in the conventional ovarian stimulation strategy (mean difference -1.2 days, 95% CI: -1.88 to -0.62). Also, a significantly lower amount of gonadotropins was used in the mild simulation strategy, with a mean difference of 3135 IU (95% CI: -3331 to -2940). LIMITATIONS, REASONS FOR CAUTION: A limitation of our study was the lack of data concerning the cryopreservation of surplus embryos, so we are not informed on cumulative pregnancy rates. Another limitation is that we were not able to follow up on the ongoing pregnancies in all centers, so we are not informed on live birth rates. WIDER IMPLICATIONS OF THE FINDINGS: The results are directly applicable in daily clinical practice and may lead to considerable cost savings as high dosages of gonadotropins are not necessary in women with poor ovarian reserve undergoing IVF. A health economic analysis of our data planned to test the hypothesis that mild ovarian stimulation strategy is more cost-effective than the conventional ovarian stimulation strategy is underway. STUDY FUNDING/COMPETING INTERESTS: This study was supported by NUFFIC scholarship (the Netherlands) and STDF short-term fellowship (Egypt). TRIAL REGISTRATION NUMBER: NTR2788 (Trialregister.nl). TRIAL REGISTER DATE: 01 March 2011. DATE OF FIRST PATIENT'S ENROLMENT: May 2011.
引用
- Youssef MA, van Wely M, Al-Inany H, et al. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial. Hum Reprod. 2016. PMID: 27836979
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。